Clinical Trial: Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study to Determine the Therapeutic Equivalence of GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic
Brief Summary: This research study is being done to compare the safety and effectiveness of GDC 695 (test drug) against the currently marketed reference drug (diclofenac sodium gel, 3%) and to establish that these two drugs work better than placebo in the treatment of actinic keratosis.
Detailed Summary:
Sponsor: Gage Development Company, LLC
Current Primary Outcome: Complete Clearance [ Time Frame: Day 90 (30 days after completion of 60 days of treatment) ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Gage Development Company, LLC
Dates:
Date Received: October 31, 2016
Date Started: October 2016
Date Completion: October 2017
Last Updated: January 31, 2017
Last Verified: January 2017